Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

SC Pharmaceuticals Inc (SCPH)

SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

SC Pharmaceuticals Inc 25 BURLINGTON MALL ROAD SUITE 203 BURLINGTON MA 01803 USA

www.scpharma.com P: 617-517-0730

Description:

scPharmaceuticals, Inc., is a biopharmaceutical company. It engaged in developing pharmaceutical products for subcutaneous delivery. The Company's pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. scPharmaceuticals, Inc., is based in BURLINGTON, United States.

Key Statistics

Overview:

Market Capitalization, $K 161,161
Enterprise Value, $K 153,341
Shares Outstanding, K 36,054
Annual Sales, $ 13,590 K
Annual Net Income, $ -54,810 K
Last Quarter Sales, $ 6,100 K
Last Quarter Net Income, $ -13,810 K
EBIT, $ -55,400 K
EBITDA, $ -55,380 K
60-Month Beta 0.06
% of Insider Shareholders 4.68%
% of Institutional Shareholders 89.52%
Float, K 34,367
% Float 95.32%
Short Volume Ratio 0.48

Growth:

1-Year Return -53.34%
3-Year Return -24.46%
5-Year Return 29.71%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 10.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 03/13/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm -1.42
EPS Growth vs. Prev Qtr 14.63%
EPS Growth vs. Prev Year -16.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SCPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -97.18%
Return-on-Assets % -49.59%
Profit Margin % -403.31%
Debt/Equity 1.05
Price/Sales 12.15
Price/Cash Flow N/A
Price/Book 4.33
Book Value/Share 1.04
Interest Coverage -5.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar